retatrutide study results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial 🚨 Today, retatrutide, the GIP/GLP-1/glucagon

The clinical data identifies several clear predictors

If prescribed, your medication will be shipped discreetly to your door

It is cold, fast, easy to portion, and easier to start than something heavier

Severe caloric restriction (under 800 to 1000 calories daily for extended periods) while on retatrutide leads to excessive muscle loss, hair shedding , fatigue , nutrient deficiencies, and metabolic adaptation that slows long-term progress

An authorized generic (AG) version launched in the U.S

Possible effects include: Loose or excess skin Fatigue Hair thinning Muscle loss (if not strength training) Gallbladder issues with rapid loss Nutrient deficiencies if diet is poor Most risks are reduced with gradual weight loss, adequate protein, strength training, and medical supervision